CL2015001532A1 - Nanofibras de quitosano contenedoras de compuestos bioactivos - Google Patents

Nanofibras de quitosano contenedoras de compuestos bioactivos

Info

Publication number
CL2015001532A1
CL2015001532A1 CL2015001532A CL2015001532A CL2015001532A1 CL 2015001532 A1 CL2015001532 A1 CL 2015001532A1 CL 2015001532 A CL2015001532 A CL 2015001532A CL 2015001532 A CL2015001532 A CL 2015001532A CL 2015001532 A1 CL2015001532 A1 CL 2015001532A1
Authority
CL
Chile
Prior art keywords
bioactive compounds
containing bioactive
nanofibers containing
chitosan nanofibers
nanofibers
Prior art date
Application number
CL2015001532A
Other languages
English (en)
Inventor
Ariadne Zuñiga Garay Elisa
Cesar Muñoz Carvajal Pablo
Enrique Rubilar Rubilar Osvaldo
Original Assignee
Fundación Copec Universidad Católica
Univ De Valparaiso
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundación Copec Universidad Católica, Univ De Valparaiso filed Critical Fundación Copec Universidad Católica
Priority to CL2015001532A priority Critical patent/CL2015001532A1/es
Publication of CL2015001532A1 publication Critical patent/CL2015001532A1/es
Priority to PCT/CL2016/050030 priority patent/WO2016191895A1/es
Priority to EP16802314.1A priority patent/EP3305303A4/en
Priority to US15/579,886 priority patent/US11357737B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NANOFIBRAS DE QUITOSANO AUTOENSAMBLADA CONTENEDORAS DE COMPUESTOS BIOACTIVOS DE TAMAÑO MOLECULAR MENOR A 0,5 KDA Y QUE PRESENTAN GRUPOS ACIDOS O LACTONAS, ANILLOS AROMATICOS E HIDROXILOS; METODO PARA FORMAR LAS NANOFIBRAS Y COMPOSICION FARMACEUTICA O NUTRACEUTICA QUE LAS COMPRENDE.
CL2015001532A 2015-06-05 2015-06-05 Nanofibras de quitosano contenedoras de compuestos bioactivos CL2015001532A1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CL2015001532A CL2015001532A1 (es) 2015-06-05 2015-06-05 Nanofibras de quitosano contenedoras de compuestos bioactivos
PCT/CL2016/050030 WO2016191895A1 (es) 2015-06-05 2016-06-04 Nanofibras de quitosano contenedoras de compuestos bioactivos
EP16802314.1A EP3305303A4 (en) 2015-06-05 2016-06-04 CHITOSAN NANOFIBERS COMPRISING BIOACTIVE COMPOUNDS
US15/579,886 US11357737B2 (en) 2015-06-05 2016-06-04 Chitosan nanofibers containing bioactive compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2015001532A CL2015001532A1 (es) 2015-06-05 2015-06-05 Nanofibras de quitosano contenedoras de compuestos bioactivos

Publications (1)

Publication Number Publication Date
CL2015001532A1 true CL2015001532A1 (es) 2015-12-28

Family

ID=56080973

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015001532A CL2015001532A1 (es) 2015-06-05 2015-06-05 Nanofibras de quitosano contenedoras de compuestos bioactivos

Country Status (4)

Country Link
US (1) US11357737B2 (es)
EP (1) EP3305303A4 (es)
CL (1) CL2015001532A1 (es)
WO (1) WO2016191895A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108771668B (zh) * 2018-07-24 2019-10-08 四川九章生物科技有限公司 一种用于治疗肌萎缩性脊髓侧索硬化症的联合用药组合物及其制备方法和用途
EP3880747A4 (en) * 2018-11-15 2022-08-31 Psigryph Inc. NANOFIBERS DERIVED FROM PLANT TISSUE
CN113336870B (zh) * 2021-05-21 2023-04-25 珠海市自然之旅生物技术有限公司 一种托酚酮-壳聚糖衍生物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0126923D0 (en) * 2001-11-09 2002-01-02 Procter & Gamble Chitosan compositions
DE102004040243A1 (de) * 2003-08-22 2005-03-17 Heppe, Katja, Dipl.-Biotechnol. Transportsystem auf Chitosanbasis
BRPI0913266A2 (pt) * 2008-05-30 2016-01-26 Panacea Biotec Ltd composições compreendendo euphorbia prostrata e processo de preparação das mesmas
US20170238569A1 (en) * 2016-02-23 2017-08-24 Empire Technology Development Llc Edible food preservative

Also Published As

Publication number Publication date
US11357737B2 (en) 2022-06-14
EP3305303A1 (en) 2018-04-11
WO2016191895A1 (es) 2016-12-08
EP3305303A4 (en) 2019-02-06
US20180169031A1 (en) 2018-06-21

Similar Documents

Publication Publication Date Title
CY1122994T1 (el) Μεθοδος καθαρισμου κανναβινοειλων, συνθεσεων και kit αυτων
BR112019006106A2 (pt) formulação carregada com canabinoide, processo para preparar a formulação carregada com canabinoide, composições farmacêutica e nutracêutica, e, método de tratamento de um indivíduo sofrendo de uma enfermidade ou um distúrbio.
BR112017026245A2 (pt) microcápsulas com alta deposição em superfícies
BR112018010683B8 (pt) Método para produzir uma composição de glucano
BR112017010173A2 (pt) composição para tratamento de tecido
MX2022015755A (es) Profarmacos de hormona paratiroidea (pth).
BR112016028283A2 (pt) produto de semente revestida e método para formação do mesmo
EP3398948A3 (en) 2,4,6,7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
BR112019006642A2 (pt) antagonistas multiméricos de e-selectina altamente potentes
BR112017010177A2 (pt) composição para tratamento de tecido
BR112017003346A2 (pt) derivados de pirazolopiridina, seus usos, e composição farmacêutica
CR20170009A (es) Composiciones y Métodos para Empacar Productos
BR112016025876A8 (pt) composição, processos para preparar uma microcápsula e uma forma de dosagem unitária, forma de dosagem unitária, microcápsula, produto, uso de uma composição, e, método para tratar uma condição associada à vitamina k1 ou k2
MX2019004319A (es) Acorde de floracion de alto rendimiento, alto impacto.
BR112017000898A2 (pt) oritavancina de alta pureza e método de produção da mesma
BR112016028316A2 (pt) composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento
BR112018010267A2 (pt) antibióticos macrocíclicos de amplo espectro
CL2015001532A1 (es) Nanofibras de quitosano contenedoras de compuestos bioactivos
BR112017022523A2 (pt) ?formulação para cápsulas de gel, cápsula de gel, e, processo?.
BR112018008588A2 (pt) composição, e, processo para preparar uma composição.
EA201790321A1 (ru) Эластомерные композиции, содержащие усниновую кислоту, и изделия, изготовленные из них или покрытые ими
ECSP17021465A (es) Formulación que comprende glicopirrolato, método y aparato
BR112017011226A2 (pt) peptídeo, composição farmacêutica, processo para fabricação da composição farmacêutica
BR112017001963A2 (pt) composição farmacêutica oral, seu processo de preparação e método de tratamento
BR112018010767A8 (pt) revestimento comestível, sistema de produtos comestíveis apresentando o referido revestimento comestível e uso do referido sistema